Fliri
Anton Fliri, Stonington, CT US
| Patent application number | Description | Published |
|---|---|---|
| 20090132464 | Methods for processing generic chemical structure representations - The invention relates to machine assisted analysis of information encoded by generic chemical structure representations, and to methods for processing these structures. | 05-21-2009 |
| 20100205214 | Method for Creating Virtual Compound Libraries Within Markush Structure Patent Claims - A machine-implemented method creates collections of chemical structures exhibiting a certain degree of structural similarity with exemplified compounds. Specific examples are extracted from a patent. Molecular structure fingerprints are calculated for the specific examples. Markush structure topology information is obtained from a patent database. Virtual libraries are enumerated using the Markush structure topology information extracted from the database. Molecular structure fingerprint similarity of exemplified compounds is identified by comparing the fingerprints with the molecular fingerprints calculated from a randomly enumerated set of chemical compounds. A subset of randomly enumerated chemical structures, which exhibit a similarity range within a user specified similarity range with the fingerprint calculated from the exemplified compounds, is then selected. | 08-12-2010 |
Antone F.j. Fliri, Stonington, CT US
| Patent application number | Description | Published |
|---|---|---|
| 20110172297 | Oxopiperdinyl And Pyranyl Sulfonamides and Pharmaceutical Compositions Thereof - The invention is directed to a class of compounds, including the pharmaceutically acceptable salts of the compounds, having the structure of Formula (I): as defined in the specification. The invention is also directed to compositions containing the compounds of Formula (I) as AMPA modulators. | 07-14-2011 |
Anton F.j. Fliri, Stonington, CT US
| Patent application number | Description | Published |
|---|---|---|
| 20100035865 | Sulfonamides and Pharmaceutical Compositions Thereof - The invention is directed to a class of compounds, including the pharmaceutically acceptable salts of the compounds, having the structure of formula (I), as defined in the specification. The invention is also directed to compositions containing the compounds of formula (I). | 02-11-2010 |
Anton F. J. Fliri, Stonington, CT US
| Patent application number | Description | Published |
|---|---|---|
| 20110105533 | Heterocyclic Sulfonamides, Uses and Pharmaceutical Compositions Thereof - The invention is directed to a class of compounds, including the pharmaceutically acceptable salts of the compounds, having the structure of formula I: | 05-05-2011 |
| 20120322823 | HETEROCYCLIC SULFONAMIDES, USES AND PHARMACEUTICAL COMPOSITIONS THEREOF - The invention is directed to a class of compounds, including the pharmaceutically acceptable salts of the compounds, having the structure of formula I: | 12-20-2012 |
Anton Franz Joseph Fliri, Stonington, CT US
| Patent application number | Description | Published |
|---|---|---|
| 20140323416 | 5-METHYLDIHYDROMORPHONE COMPOUNDS FOR TREATMENT OF PAIN - The aspects of the present disclosure are directed to novel compounds, formulations containing said compounds or pharmaceutically acceptable salts thereof which are suitable for administration to a patient. In particular, to 5-methyldihydromorphone prodrug compounds described in general Formula I and II and the use of the compounds for treating pain associated with a variety of chronic human disorders including for example neuropathic pain and pain associated with cancer, surgeries or injuries. | 10-30-2014 |
| 20140323502 | HETEROCYCLIC SULFONAMIDES, USES AND PHARMACEUTICAL COMPOSITIONS THEREOF - The invention is directed to a class of compounds, including the pharmaceutically acceptable salts of the compounds, having the structure of formula I: | 10-30-2014 |
Hans Fliri, Essex GB
| Patent application number | Description | Published |
|---|---|---|
| 20100010027 | ABNORMAL CANNABIDIOLS AS AGENTS FOR LOWERING INTRAOCULAR PRESSURE - The present invention provides a method of treating glaucoma or ocular hypertension which comprises applying to the eye of a person in need thereof an amount sufficient to treat glaucoma or ocular hypertension of a compound of formula I | 01-14-2010 |
Hans Fliri, Saffron Waldon GB
| Patent application number | Description | Published |
|---|---|---|
| 20150284400 | CANNABINOID-2 AGONISTS - The present specification discloses cannabinoid-2 agonists, compositions comprising such cannabinoid-2 agonists, and methods of treating an individual suffering from a disease by administering compositions comprising such cannabinoid-2 agonists. | 10-08-2015 |
Hans G. Fliri, Essex GB
| Patent application number | Description | Published |
|---|---|---|
| 20110269715 | ABNORMAL CANNABIDIOLS AS AGENTS FOR LOWERING INTRAOCULAR PRESSURE - The present invention provides a method of treating glaucoma or ocular hypertension which comprises applying to the eye of a person in need thereof an amount sufficient to treat glaucoma or ocular hypertension of a compound of formula I | 11-03-2011 |
| 20130022573 | MACROCYCLIC INHIBITORS OF FLAVIVIRIDAE VIRUSES - Provided are compounds of Formula I: | 01-24-2013 |
| 20140023616 | MACROCYCLIC INHIBITORS OF FLAVIVIRIDAE VIRUSES - Provided are compounds of Formula I: | 01-23-2014 |
Hans Georg Fliri, Saffron Walden GB
| Patent application number | Description | Published |
|---|---|---|
| 20120264679 | 3-ETHER AND 3-THIOETHER SUBSTITUTED CYCLOSPORIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF HEPATITIS C INFECTION - This invention relates to cyclosporin derivatives of general formula (I): | 10-18-2012 |
Hans Georg Fliri, Saffron GB
| Patent application number | Description | Published |
|---|---|---|
| 20100167996 | 3-Ether and 3-Thioether Substituted Cyclosporin Derivatives For the Treatment and Prevention of Hepatitis C Infection - This invention relates to cyclosporin derivatives of general formula (I): | 07-01-2010 |
Hans Georg Fliri, Ongar GB
| Patent application number | Description | Published |
|---|---|---|
| 20150259317 | PROTECTED SUCCINATES FOR ENHANCING MITOCHONDRIAL ATP-PRODUCTION - Disclosed herein are mono or di-succinate compounds where one or both of the acid groups in the succinate core are protected in the form of biologically labile moieties, and the use of said compounds to enhance mitochondrial function. The compounds may be of formula (I) wherein R | 09-17-2015 |
| 20150259386 | CYCLIC DEPSIPEPTIDE COMPOUNDS AND THEIR USES - The present invention relates to novel cycloundecadepsipeptide compounds and their analogues which bind and inhibit cyclophilins, have reduced immunosuppressive activity and improved physicochemical properties including water solubility. The present invention further relates to pharmaceutical compositions containing said depsipeptide compounds and their analogues for use in the treatment or prevention of diseases and pathologies which may be ameliorated by the inhibition of cyclophilin activity. | 09-17-2015 |
Robert Fliri, Meran (bz) IT
| Patent application number | Description | Published |
|---|---|---|
| 20100299962 | FOOTWEAR HAVING INDEPENDENTLY ARTICUABLE TOE PORTIONS - Footwear including a sole, an upper, and a securement arrangement configured to secure the footwear to the foot of a wearer, where the sole and the upper delimit individual toe portions configured to receive, retain, and allow independent articulation of corresponding individual toes of a foot inserted in the footwear, and where the sole includes contouring and curvature which intimately corresponds to the shape of the foot. | 12-02-2010 |
| 20120000094 | FOOTWEAR HAVING INDEPENDENTLY ARTICUABLE TOE PORTIONS - Footwear including a sole, an upper, and a securement arrangement configured to secure the footwear to the foot of a wearer, where the sole and the upper delimit individual toe portions configured to receive, retain, and allow independent articulation of corresponding individual toes of a foot inserted in the footwear, and where the sole includes contouring and curvature which intimately corresponds to the shape of the foot. | 01-05-2012 |